Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair Cases
Launched by MICHAEL A BELFORT · Jan 3, 2023
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the safety and effectiveness of special devices used during a surgery called fetoscopic neural tube defect repair. This surgery is performed on expectant mothers whose babies have a condition known as a neural tube defect, which affects the development of the baby’s spine and brain. The trial is currently recruiting female patients who have chosen to undergo this type of surgery.
If you or someone you know is considering this surgery, you may be eligible to participate in the trial if you are planning to have the fetoscopic repair. Participants in the study can expect to help researchers learn more about the devices used in this procedure, which could ultimately improve care for future patients. It's important to note that only patients who agree to have the surgery can join the trial. Your involvement could contribute to advancements in how these surgeries are performed and help ensure safer outcomes for babies with neural tube defects.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients who elect to undergo fetoscopic neural tube defect repair
- Exclusion Criteria:
- • Patients who do not elect to undergo fetoscopic neural tube defect repair
About Michael A Belfort
Dr. Michael A. Belfort is a distinguished clinical trial sponsor with a robust background in obstetrics and gynecology, specializing in innovative approaches to women's health. With extensive experience in clinical research and a commitment to advancing medical science, Dr. Belfort leads initiatives aimed at evaluating novel therapies and interventions. His dedication to improving patient outcomes and safety underscores his role in overseeing rigorous trial protocols, ensuring compliance with regulatory standards, and fostering collaboration among multidisciplinary teams. Through his leadership, Dr. Belfort continues to contribute to the body of knowledge in women's health, driving forward the development of effective clinical solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Michael A Belfort, MD
Principal Investigator
Baylor College of Medicine and Texas Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials